“Over one million people worldwide suffer from severe heart failure and need mechanical circulatory support.”

A less invasive procedure, improved quality of life and a reduced risk of complications. These are some of the advantages of Prof. Jan Solem’s  invention -  an entirely new approach to the support of the cardiac function in patients with severe heart failure. The technology is applicable to a growing worldwide demographic of more than one million heart failure patients.

Two-thirds of cardiac output is due to the up-and-down movement of the mitral valve plane. The Syntach CS Device restores impaired movement of the mitral valve and naturally supports the heart. It is a permanent, active implant that can be inserted using a minimally invasive technique. It is smaller than existing left ventricle assist devices (LVADs) and is therefore suitable for both men and women of all sizes.

Syntach´s products are being developed and have not yet been approved for clinical use.